BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27244112)

  • 1. Interest of Denosumab for the Treatment of Giant-cells Tumors and Aneurysmal Bone Cysts of the Spine. About Nine Cases.
    Dubory A; Missenard G; Domont J; Court C
    Spine (Phila Pa 1976); 2016 Jun; 41(11):E654-E660. PubMed ID: 27244112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
    Al Farii H; McChesney G; Patel SS; Rhines LD; Lewis VO; Bird JE
    Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
    Mattei TA; Ramos E; Rehman AA; Shaw A; Patel SR; Mendel E
    Spine J; 2014 Jul; 14(7):e15-21. PubMed ID: 24534393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of Aneurysmal Bone Cyst to Denosumab.
    Skubitz KM; Peltola JC; Santos ER; Cheng EY
    Spine (Phila Pa 1976); 2015 Nov; 40(22):E1201-4. PubMed ID: 26730528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent giant cell tumour of the thoracic spine managed by total en bloc spondylectomy and denosumab therapy: a case report.
    Duan PG; Sheng YH; Deng CH; Tang BY; Yao HQ
    BMC Musculoskelet Disord; 2020 Feb; 21(1):105. PubMed ID: 32061254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum.
    Bukata SV; Blay JY; Rutkowski P; Skubitz K; Henshaw R; Seeger L; Dai T; Jandial D; Chawla S
    Spine (Phila Pa 1976); 2021 Mar; 46(5):277-284. PubMed ID: 33038190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
    Yonezawa N; Murakami H; Kato S; Takeuchi A; Tsuchiya H
    Eur Spine J; 2017 May; 26(Suppl 1):236-242. PubMed ID: 28396950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphologic Changes After Denosumab Therapy in Patients with Giant Cell Tumor of the Spine: Report of Four Cases and a Review of the Literature.
    Yonezawa N; Murakami H; Demura S; Kato S; Yoshioka K; Takeuchi A; Shinmura K; Yokogawa N; Shimizu T; Oku N; Kitagawa R; Handa M; Tsuchiya H
    World Neurosurg; 2019 Jul; 127():38-46. PubMed ID: 30926552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denosumab in patients with aneurysmal bone cysts: A case series with preliminary results.
    Palmerini E; Ruggieri P; Angelini A; Boriani S; Campanacci D; Milano GM; Cesari M; Paioli A; Longhi A; Abate ME; Scoccianti G; Terzi S; Trovarelli G; Franchi A; Picci P; Ferrari S; Leopardi MP; Pierini M
    Tumori; 2018 Oct; 104(5):344-351. PubMed ID: 30086700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denosumab: a potential treatment option for aneurysmal bone cyst of the atlas.
    Patel RS; Dhamne CA; Gopinathan A; Kumar N; Kumar N
    Eur Spine J; 2018 Jul; 27(Suppl 3):494-500. PubMed ID: 29470716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological Transformation of Giant-Cell Tumor of Bone After Treatment with Denosumab: A Case Report.
    Zhang Y; Ilaslan H; Krishnaney AA; Bauer TW
    JBJS Case Connect; 2016; 6(3):e74. PubMed ID: 29252651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
    Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
    Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report.
    Kinoshita H; Orita S; Yonemoto T; Ishii T; Iwata S; Kamoda H; Tsukanishi T; Inage K; Abe K; Inoue M; Norimoto M; Umimura T; Fujimoto K; Shiga Y; Kanamoto H; Furuya T; Takahashi K; Ohtori S
    J Med Case Rep; 2019 Apr; 13(1):116. PubMed ID: 31023361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab].
    Gong LH; Liu WF; Ding Y; Zhang W; Yang YK; Yu F; Wong GQ; Huang XY; Niu XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):449-454. PubMed ID: 29886590
    [No Abstract]   [Full Text] [Related]  

  • 15. Denosumab in the treatment of giant cell tumor of the spine. Preliminary report, review of the literature and protocol proposal.
    Boriani S; Cecchinato R; Cuzzocrea F; Bandiera S; Gambarotti M; Gasbarrini A
    Eur Spine J; 2020 Feb; 29(2):257-271. PubMed ID: 31098716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
    Tang Q; Lu J; Zhu X; Song G; Wu H; Xu H; Wang A; Wang J
    Eur Spine J; 2023 Dec; 32(12):4297-4305. PubMed ID: 37318598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Denosumab cure giant cell tumors of the spine? A case report and literature review.
    Xará-Leite F; Coutinho L; Fleming C; Magalhães M; Oliveira V; Rodrigues-Pinto R; Cardoso P
    Eur J Orthop Surg Traumatol; 2020 Jan; 30(1):19-23. PubMed ID: 31529151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab Treatment for Giant Cell Tumors, Aneurysmal Bone Cysts, and Fibrous Dysplasia-Risks and Benefits.
    Pan KS; Boyce AM
    Curr Osteoporos Rep; 2021 Apr; 19(2):141-150. PubMed ID: 33616817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
    Palmerini E; Chawla NS; Ferrari S; Sudan M; Picci P; Marchesi E; Leopardi MP; Syed I; Sankhala KK; Parthasarathy P; Mendanha WE; Pierini M; Paioli A; Chawla SP
    Eur J Cancer; 2017 May; 76():118-124. PubMed ID: 28324746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series.
    Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R
    World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.